Quince Therapeutics Completes Acquisition of EryDel S.p.A. :

Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics,...

Related Keywords

Thomas Sabia , Giovanni Mambrini , Brendan Hannah , Luca Benatti , Charles Ryan , Pamela Williamson , Dirk Thye , Guenterr Janhofer , Exchange Commission , Securities Exchange , Quince Therapeutics Inc , Linkedin , European Investment Bank , Nasdaq , Head Of Regulatory Affairs , Us Food Drug Administration , Quince Therapeutics , Chief Executive , Neurologic Effects , Special Protocol Assessment , Drug Administration , New Drug Application , Chief Executive Officer , Chief Medical Officer , Chief Business Officer , Principal Financial Officer , Chief Technology Officer , Chief Commercial Officer , Regulatory Affairs , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Quarterly Report , Markets ,